![Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ... Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...](https://ars.els-cdn.com/content/image/1-s2.0-S0012369221009521-fx1.jpg)
Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
![Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town | Allergo Journal International Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town | Allergo Journal International](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40629-018-0066-y/MediaObjects/40629_2018_66_Fig2_HTML.gif)
Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town | Allergo Journal International
Introduction - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
![Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis](https://www.tandfonline.com/cms/asset/08ff34d7-44ff-4230-a574-98d0adbe01df/icop_a_1170799_f0003_oc.gif)
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/4-Table1-1.png)
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
![Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? | npj Primary Care Respiratory Medicine Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpjpcrm.2014.23/MediaObjects/41533_2014_Article_BFnpjpcrm201423_Fig1_HTML.jpg)
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? | npj Primary Care Respiratory Medicine
![The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society](https://err.ersjournals.com/content/errev/31/164/210196/F1.large.jpg)
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
![Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram](https://www.researchgate.net/publication/349101597/figure/fig1/AS:1023650308300801@1621068660236/Mechanisms-of-action-of-LAMAs-ACh-acetylcholine-LAMA-longacting-muscarinic.png)
Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram
![Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram](https://www.researchgate.net/publication/347420613/figure/tbl1/AS:986275486109704@1612157808803/Long-Acting-Muscarinic-Receptor-Antagonists-LAMA-in-Clinical-Development.png)
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
![Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society](https://openres.ersjournals.com/content/erjor/5/3/00106-2019/F1.large.jpg)
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/5-Table2-1.png)
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
![Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis](https://www.tandfonline.com/cms/asset/e640efc8-1604-4594-86da-62ae82e0239d/icop_a_1170799_f0006_oc.gif)
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/5-Table3-1.png)